Inhibiting ATP6AP1 by blocking autophagy can increase drug sensitivity in breast cancer cells, thereby improving the therapeutic outcomes and overall survival of breast cancer patients (Fig. 5). This evidence concerns the gene ATP6AP1 and breast carcinoma.